OneMedNet（ONMD）8-K确认重新满足纳斯达克1美元最低买价上市规则，退市悬顶正式解除

----- form8-k.htm -----
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported):
October 13, 2026
ONEMEDNET
CORPORATION
(Exact
name of registrant as specified in its charter)
Delaware
001-40386
86-2076743
(State
or other jurisdiction
of
incorporation)
(Commission
File
Number)
(I.R.S.
Employer
Identification
No.)
6385
Old Shady Oak Road
,
Suite 250
Eden
Prairie
,
MN
55344
(Address
of Principal Executive Offices) (Zip Code)
Registrant’s
telephone number, including area code:
800
-
918-7189
Check
the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
☐
Written communication pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencements communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading
Symbol(s)
Name
of each exchange on which registered
Common
Stock, $0.0001 par value per share
ONMD
The
Nasdaq Stock Market LLC
Redeemable
Warrants, each lot of 10 warrants is exercisable for one share of Common Stock at an exercise price of $115.00 per share
ONMDW
The
Nasdaq Stock Market LLC
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 8.01.
Other Events.
As
previously disclosed, on April 14, 2026, OneMedNet Corporation (the “Company”) received a letter from the staff of the Listing
Qualifications department (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it was
not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market as set forth in Nasdaq
Listing Rule 5550(a)(2) (the “Bid Price Rule”), and providing a grace period until October 12, 2026 to regain compliance.
On
October 13, 2026, the Company received written notice (the “Notice”) from the Staff indicating that the Company has regained
compliance with the Bid Price Rule. The Notice states that for 10 consecutive business days from September 29, 2026 through October 12,
2026, the closing bid price of the Company’s common stock was at least $1.00 per share. Accordingly, the Company has regained compliance
with Nasdaq Listing Rule 5550(a)(2), and this matter is now closed.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
October 14, 2026
ONEMEDNET
CORPORATION
By:
/s/
Aaron Green
Aaron Green
Chief Executive Officer